Ting Xi Zhang

Sinopharm Guizhou Blood Products Co., Ltd. engages in the manufacture, sale, research and development of blood plasma-based biopharmaceutical products. Its products include human serum albumin, intravenous immunoglobulin, human immunoglobulin, hepatitis B immunoglobulin and tetanus human immunoglobulin. The company was founded on June 28, 2006 and is headquartered in Kaili, China.

Sinopharm Guizhou Blood Products Co., Ltd. engages in the manufacture, sale, research and development of blood plasma-based biopharmaceutical products. Its products include human serum albumin, intravenous immunoglobulin, human immunoglobulin, hepatitis B immunoglobulin and tetanus human immunoglobulin. The company was founded on June 28, 2006 and is headquartered in Kaili, China.

Sinopharm Guizhou Blood Products Co., Ltd. engages in the manufacture, sale, research and development of blood plasma-based biopharmaceutical products. Its products include human serum albumin, intravenous immunoglobulin, human immunoglobulin, hepatitis B immunoglobulin and tetanus human immunoglobulin. The company was founded on June 28, 2006 and is headquartered in Kaili, China.

Sinopharm Guizhou Blood Products Co., Ltd. engages in the manufacture, sale, research and development of blood plasma-based biopharmaceutical products. Its products include human serum albumin, intravenous immunoglobulin, human immunoglobulin, hepatitis B immunoglobulin and tetanus human immunoglobulin. The company was founded on June 28, 2006 and is headquartered in Kaili, China.

Sinopharm Guizhou Blood Products Co., Ltd. engages in the manufacture, sale, research and development of blood plasma-based biopharmaceutical products. Its products include human serum albumin, intravenous immunoglobulin, human immunoglobulin, hepatitis B immunoglobulin and tetanus human immunoglobulin. The company was founded on June 28, 2006 and is headquartered in Kaili, China.